Shares in Eli Lilly were tracking down this morning after the company revealed data on its oral weight-loss candidate, orforglipron, that seems to have once again disappointed investors. The results come from the ATTAIN-1 study, which was teased earlier this year, but has now been presented in full at the EASD congress and simultaneously published…
Novo Nordisk plans to examine in clinical trials whether its future weight-loss drugs can treat a wide range of health conditions linked to obesity, as it has already begun doing with its blockbuster drug Wegovy. The Danish drugmaker aims to build evidence across both severe and more common obesity-related conditions that affect patients’ daily lives,…
The UK is losing out to competitors in attracting investment in R&D, clinical trials, and capital projects due to a stubborn refusal to pay for innovative new medicines, according to the pharma industry. A report on pharma competitiveness, published by the Association of the British Pharmaceutical Industry (ABPI), claims that the UK’s position for attracting…
The first child to receive a new experimental gene therapy for a rare neurological disorder died a few days after dosing, the company sponsoring that trial said Wednesday. The company, Capsida Biotherapeutics, is one of a group of companies and labs engineering new viruses potentially capable of safely ferrying genes deep into the brain. Its…
Eli Lilly’s fast-growing blood cancer drug Jaypirca could gain additional momentum thanks to a new trial suggesting it could move into the first-line setting. Reversible BTK inhibitor Jaypirca (pirtobrutinib) has been shown in the BRUIN CLL-313 to significantly improve progression-free survival compared to standard chemoimmunotherapy (CIT) in previously untreated patients with chronic lymphocytic leukaemia or…
Russia’s Enteromix Cancer Vaccine Shows 100% Success in Trial, Awaits Final Nod for Public Use We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
New Delhi: The Centre is set to amend the New Drugs and Clinical Trials Rules, 2019, that would halve the statutory time to process applications for test licences to manufacture or use a new drug in clinical trials, promoting ease of doing business in the pharmaceutical sector. The Union health ministry sought public comments on…
Shocking! 1,705 deaths in Clinical Trials Since 2021, reveals RTI We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Health Bulletin 01/September/2025 We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
One Death a Day: 1,705 Lives Lost in India’s Clinical Trials Since 2021, RTI Reveals We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link